Clinical Characteristics and Outcomes of Relapsed Follicular Lymphoma After Autologous Stem Cell Transplantation at Rituximab Era

Clinical trial NCT03663894 · COMPLETED

Trial details

NCT number: NCT03663894
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Study type: OBSERVATIONAL

Patient's Outcome Prognostic Factors

Start date: 2017-07-30
Primary completion: 2017-12-15
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.